Impact of COVID-19 on hepatitis elimination (a modelling perspective) - Shevanthi Nayagam

International Viral Hepatitis Elimination Meeting (IVHEM) 2020

Bakary Dibba_COLDA2024_Abstract.pdf

Conference on Liver Disease in Africa (COLDA) 2024

Transmitted Drug Resistance in HIV-Infected Treatment-Naïve Patients in Chile between 2014 and 2017- Dr. Palma

Andean Pacific Workshop on HIV & Hepatitis 2017

Transitioning to use of Integrase Inhibitors in Brazil- Estevão Nunes

Brazilian HIV Clinical Forum 2018

Clinical Case Presentation - Max Igor Lopes, MD

São Paulo HIV Clinical Forum 2022

Nathan Ford, MPH, PhD, FRCPE - Rapid Start Concept

African HIV Clinical Forum 2022

Seroprevalence and Correlates of Co-infection With HIV and Active Syphilis Among Women in Six Sub-Saharan African Countries - Results From Population-Based HIV Impact Assessments (PHIAs).pdf

International Workshop on HIV & Women 2024

09_Arends

Workshop on HCV Therapy Advances – New Antivirals in Clinical Practice 2015

Hepatitis B virus infection in HIV-seronegative and HIVseropositive MSM in West Africa: prevalence, associated factors, and acceptability of vaccination (CohMSM ANRS 12324 – Expertise France)- T.T.E. Dah

INTEREST 2017

Next generation sequencing for routine HIV-1 resistance genotyping in a clinical laboratory: unsolved issues

European Meeting on HIV & Hepatitis 2020